// App-Quantinova.ai

: The incidence and risk factors of radioiodine-induced graves’ disease following treatment of thyroid autonomous tissue

Researchers

Presenter

  • Tjasa Zaletel

Principal Investigators

  • Ziva Rot

  • Danijela Krkovic

  • Simona Gaberscek

  • Katja Zaletel

Medical Centers

  • University Medical Centre Ljubljana, University of Ljubljana, Faculty of Medicine, University Medical Centre Ljubljana, Department of Nuclear Medicine, Ljubljana, Slovenia

  • University Medical Centre Ljubljana, Department of Nuclear Medicine, Ljubljana, Slovenia

  • University Medical Centre Ljubljana, University of Ljubljana, Faculty of Medicine, University Medical Centre Ljubljana, Department of Nuclear Medicine, Ljubljana, Slovenia

  • University of Cambridge School of Clinical Medicine, United Kingdom

  • Department of Nuclear Medicine, University Medical Centre Maribor, Maribor, Slovenia

Locations

  • United Kingdom

  • Slovenia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Thyroglobulin Auto-antibodies

Drug/Treatment

  • I-123

  • I 131

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved